Compile Data Set for Download or QSAR
Report error Found 727 Enz. Inhib. hit(s) with Target = 'Histone-lysine N-methyltransferase EZH2 [Y641F]'
TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM458816(N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-...)
Affinity DataIC50: 0.300nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM458816(N-((4-Methoxy-6-methyl-2-oxo-1,2-dihydropyridin-3-...)
Affinity DataIC50: 0.300nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172085(US9090562, 91 | US10155002, Compound 91 | US110520...)
Affinity DataIC50: 0.520nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172085(US9090562, 91 | US10155002, Compound 91 | US110520...)
Affinity DataIC50: 0.520nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172085(US9090562, 91 | US10155002, Compound 91 | US110520...)
Affinity DataIC50: 0.520nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172163(US9090562, 171 | US10155002, Compound 171 | US1105...)
Affinity DataIC50: 0.760nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172163(US9090562, 171 | US10155002, Compound 171 | US1105...)
Affinity DataIC50: 0.760nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172163(US9090562, 171 | US10155002, Compound 171 | US1105...)
Affinity DataIC50: 0.760nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM458826(6-((1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)(ethyl...)
Affinity DataIC50: 0.800nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM458826(6-((1,1-Dioxidotetrahydro-2H-thiopyran-4-yl)(ethyl...)
Affinity DataIC50: 0.800nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172087(US9090562, 93 | US10155002, Compound 93 | US110520...)
Affinity DataIC50: 0.870nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172087(US9090562, 93 | US10155002, Compound 93 | US110520...)
Affinity DataIC50: 0.870nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172087(US9090562, 93 | US10155002, Compound 93 | US110520...)
Affinity DataIC50: 0.870nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM310800(US10150764, Compound 86)
Affinity DataIC50: 1nMAssay Description:The assays were performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG, 100 mM KCl and 0.002% Tween20, prepared on the day...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172080(US9090562, 86 | US10155002, Compound 86 | US110520...)
Affinity DataIC50: 1.12nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172080(US9090562, 86 | US10155002, Compound 86 | US110520...)
Affinity DataIC50: 1.12nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172080(US9090562, 86 | US10155002, Compound 86 | US110520...)
Affinity DataIC50: 1.12nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM190204(US9175331, 35 | EPZ008491)
Affinity DataIC50: 1.40nMAssay Description:Test compounds were serially diluted 3-fold in DMSO in a 10 point-curve and 1 uL was spotted into a 384-well microplate in duplicate using a Platemat...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM190202(US9175331, 32 | EPZ008337)
Affinity DataIC50: 1.5nMAssay Description:Test compounds were serially diluted 3-fold in DMSO in a 10 point-curve and 1 uL was spotted into a 384-well microplate in duplicate using a Platemat...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172174(US9175331, 44 | US9090562, 182 | EPZ008681 | US101...)
Affinity DataIC50: 1.5nMAssay Description:Test compounds were serially diluted 3-fold in DMSO in a 10 point-curve and 1 uL was spotted into a 384-well microplate in duplicate using a Platemat...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172089(US9090562, 95 | US10155002, Compound 95 | US110520...)
Affinity DataIC50: 1.55nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172089(US9090562, 95 | US10155002, Compound 95 | US110520...)
Affinity DataIC50: 1.55nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172089(US9090562, 95 | US10155002, Compound 95 | US110520...)
Affinity DataIC50: 1.55nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM190223(US9175331, 60 | EPZ009158)
Affinity DataIC50: 1.60nMAssay Description:Test compounds were serially diluted 3-fold in DMSO in a 10 point-curve and 1 uL was spotted into a 384-well microplate in duplicate using a Platemat...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172162(US9090562, 170 | US10155002, Compound 170 | US1105...)
Affinity DataIC50: 1.63nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172162(US9090562, 170 | US10155002, Compound 170 | US1105...)
Affinity DataIC50: 1.63nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172162(US9090562, 170 | US10155002, Compound 170 | US1105...)
Affinity DataIC50: 1.63nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172181(US9090562, 189 | US10155002, Compound 189 | US1105...)
Affinity DataIC50: 1.82nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172181(US9090562, 189 | US10155002, Compound 189 | US1105...)
Affinity DataIC50: 1.82nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172181(US9090562, 189 | US10155002, Compound 189 | US1105...)
Affinity DataIC50: 1.82nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172135(US9175331, 13 | US9090562, 141 | EPZ007210 | US101...)
Affinity DataIC50: 1.95nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172135(US9175331, 13 | US9090562, 141 | EPZ007210 | US101...)
Affinity DataIC50: 1.95nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172135(US9175331, 13 | US9090562, 141 | EPZ007210 | US101...)
Affinity DataIC50: 1.95nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172088(US9090562, 94 | US10155002, Compound 94 | US110520...)
Affinity DataIC50: 2.07nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172088(US9090562, 94 | US10155002, Compound 94 | US110520...)
Affinity DataIC50: 2.07nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172088(US9090562, 94 | US10155002, Compound 94 | US110520...)
Affinity DataIC50: 2.07nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172065(US9090562, 71 | US10155002, Compound 71 | US110520...)
Affinity DataIC50: 2.19nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172065(US9090562, 71 | US10155002, Compound 71 | US110520...)
Affinity DataIC50: 2.19nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172065(US9090562, 71 | US10155002, Compound 71 | US110520...)
Affinity DataIC50: 2.19nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172173(US9090562, 181 | US10155002, Compound 181 | US1105...)
Affinity DataIC50: 2.23nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172173(US9090562, 181 | US10155002, Compound 181 | US1105...)
Affinity DataIC50: 2.23nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172173(US9090562, 181 | US10155002, Compound 181 | US1105...)
Affinity DataIC50: 2.23nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50287277(CHEMBL4170753 | US10759787, Example 18 | US1105981...)
Affinity DataIC50: 2.30nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM50287277(CHEMBL4170753 | US10759787, Example 18 | US1105981...)
Affinity DataIC50: 2.30nMAssay Description:The activity of EZH2 enzyme (with A677G mutant or Y641F mutant) was tested by the following method.The method was used to determine the inhibitory ef...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM190199(US9175331, 29 | EPZ008286)
Affinity DataIC50: 2.5nMAssay Description:Test compounds were serially diluted 3-fold in DMSO in a 10 point-curve and 1 uL was spotted into a 384-well microplate in duplicate using a Platemat...More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172093(US9090562, 99 | US10155002, Compound 99 | US110520...)
Affinity DataIC50: 2.56nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172093(US9090562, 99 | US10155002, Compound 99 | US110520...)
Affinity DataIC50: 2.56nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172093(US9090562, 99 | US10155002, Compound 99 | US110520...)
Affinity DataIC50: 2.56nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172063(US9090562, 69 | US10155002, Compound 69 | US110520...)
Affinity DataIC50: 2.60nMT: 2°CAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

TargetHistone-lysine N-methyltransferase EZH2 [Y641F](Human)
Jiangsu Hengrui Medicine

US Patent
LigandPNGBDBM172063(US9090562, 69 | US10155002, Compound 69 | US110520...)
Affinity DataIC50: 2.60nMAssay Description:The assays were all performed in a buffer consisting of 20 mM bicine (pH=7.6), 0.5 mM DTT, 0.005% BSG and 0.002% Tween20, prepared on the day of use....More data for this Ligand-Target Pair
In DepthDetails
US Patent

Displayed 1 to 50 (of 727 total ) | Next | Last >>
Jump to: